Literature DB >> 4994176

Possible new metabolites mediating actions of L-dopa.

T L Sourkes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4994176     DOI: 10.1038/229413a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Effects of tetrahydropapaveroline and salsolinol on cerebral monoamine metabolism and their interactions with psychopharmacological drugs.

Authors:  N Awazi; H C Guldberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

2.  Effect of L-dopa on delayed response and visual discrimination in cats and its relation to brain chemistry.

Authors:  A Kitsikis; A G Roberge; G Frenette
Journal:  Exp Brain Res       Date:  1972       Impact factor: 1.972

3.  Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects.

Authors:  P Dostert; M S Benedetti; V Bellotti; C Allievi; G Dordain
Journal:  J Neural Transm Gen Sect       Date:  1990

4.  Chronic L-DOPA treatment of mice: a behavioural and biochemical study.

Authors:  R Bailey; E Crisp; D M Jackson; O Jenkins
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 5.  Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases.

Authors:  P Dostert; M Strolin Benedetti; G Dordain
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  Subacute L-DOPA in mice: biochemical and behavioural effects.

Authors:  O Jenkins; R Bailey; E Crisp; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 7.  1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application.

Authors:  Lucyna Antkiewicz-Michaluk; Agnieszka Wąsik; Jerzy Michaluk
Journal:  Neurotox Res       Date:  2013-05-30       Impact factor: 3.911

Review 8.  L-DOPA.

Authors:  Oleh Hornykiewicz
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.